David Snipelisky, MD
Advanced Heart Failure and Transplant Cardiology · Weston, FLNPI 1699069088
Payments from drug & device makers
Across 722 payments — averaging $535.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$171K
- AstraZeneca$136K
- Impulse Dynamics (USA) Inc.$62K
- Abbott$7K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
- W. L. Gore & Associates, Inc.$2K
- plus $7K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 252 | $171,092 |
| AstraZeneca(2 entities) | 23 | $135,501 |
| Impulse Dynamics (USA) Inc. | 95 | $62,466 |
| Abbott | 119 | $6,653 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $2,124 |
| W. L. Gore & Associates, Inc. | 4 | $1,810 |
| Novartis | 96 | $1,323 |
| Abiomed | 6 | $1,202 |
| Medtronic(2 entities) | 11 | $858 |
| Boston Scientific | 12 | $493 |
| Biosense Webster, Inc. | 12 | $459 |
| Boehringer Ingelheim | 12 | $413 |
| Cvrx, Inc. | 6 | $316 |
| Johnson & Johnson | 18 | $307 |
| E.r. Squibb & Sons, L.L.C. | 16 | $261 |
| Vifor Pharma, Inc. | 6 | $215 |
| Amgen | 10 | $202 |
| Alnylam Pharmaceuticals Inc. | 5 | $143 |
| Cardiva Medical, Inc. | 3 | $126 |
| Bridgebio Pharma, Inc. | 4 | $96 |
| Cordis US CORP. | 1 | $87 |
| Endotronix, Inc. | 1 | $83 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $39 |
| Procyrion, Inc. | 1 | $35 |
| Heartflow, Inc. | 1 | $30 |
| Amarin Pharma, Inc. | 1 | $24 |
| Scpharmaceuticals Inc. | 1 | $19 |
| Atricure, Inc. | 1 | $18 |
| Chiesi USA, Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
How this compares
$386,424 in reported general payments places this provider in the 85th percentile of 48 advanced heart failure and transplant cardiology providers in Florida.
See all advanced heart failure and transplant cardiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Weston
- David BaranWeston$435K
- Antonio Lewis CamargoWeston$7K
- Omar Wever-PinzonMiami$1.2M
- Stacy MandrasOrlando$959K
- Kelly McCantsWinter Park$475K
- Andrija VidicOrlando$449K
- Naveen BellamOrlando$414K
- Sandra ChaparroMiami$352K
- Phillip HabibDelray Beach$340K
- Waqas GhummanAtlantis$296K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.